Inventor

Stephen C. Harrison

Inventor

Brighton, MA, US

Overview

15→

Patents

2003–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 15 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides22%

C12NMicroorganisms or enzymes21%

A61KPreparations for medical, dental or toiletry purposes18%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology7%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%

G01NInvestigating or analysing materials by determining their chemical or physical properties4%

G06FElectric digital data processing3%

Y02ATechnologies for adaptation to climate change3%

PatentTitleYear

10,835,599Methods to identify prime and boost immunogens for use in a B cell lineage-based vaccination protocol2020 10,653,770Biochemically stabilized HIV-1 Env trimer vaccine2020 10,463,729Biochemically stabilized HIV-1 env trimer vaccine2019 10,307,478Biochemically stabilized HIV-1 Env trimer vaccine2019 10,192,025Rotavirus particles with chimeric surface proteins2019 10,092,638GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus2018 10,040,826Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens2018 9,950,060Biochemically stabilized HIV-1 Env trimer vaccine2018 9,718,873'Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin'2017 9,707,289'Biochemically stabilized HIV-1 ENV trimer vaccine'2017 8,741,310'Fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies'2014 8,685,411'Rotavirus antigens'2014 8,673,552'Druggable regions in the dengue virus envelope glycoprotein and methods of using the same'2014 7,524,624'Druggable regions in the dengue virus envelope glycoprotein and methods of using the same'2009 6,551,597'Vaccine compositions for human papillomavirus'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2014Based in Cambridge, MA, US· patent location history

2009–2020Patents assigned to CHILDRENS MEDICAL CENTER (12)· patent assignee history

2014–2017Patents assigned to HARRISON STEPHEN C (4)· patent assignee history

2014–2017Patents assigned to CHEN BING (2)· patent assignee history

2014–2020Based in Brighton, MA, US· patent location history

2017–2020Patents assigned to UNIV DUKE (4)· patent assignee history

2018–2020Patents assigned to BETH ISRAEL DEACONESS MEDICAL CT INC (4)· patent assignee history

2018–2020Based in Boston, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CHILDRENS MEDICAL CENTER	12	2009–2020
BETH ISRAEL DEACONESS MEDICAL CT INC	4	2018–2020
HARRISON STEPHEN Cself	4	2014–2017
UNIV DUKE	4	2017–2020
CHEN BING	2	2014–2017

Locations

Location	Patents	Span
Brighton, Massachusetts, US	7	2014–2020
Boston, Massachusetts, US	4	2018–2020
Cambridge, Massachusetts, US	4	2003–2014